Mechanism of activation and regulation of deubiquitinase activity in MINDY1 and MINDY2

被引:17
|
作者
Rehman, Syed Arif Abdul [1 ]
Armstrong, Lee A. [1 ]
Lange, Sven M. [1 ]
Kristariyanto, Yosua Adi [1 ]
Grawert, Tobias W. [2 ]
Knebel, Axel [1 ]
Svergun, Dmitri, I [2 ]
Kulathu, Yogesh [1 ]
机构
[1] Univ Dundee, Sch Life Sci, MRC Prot Phosphorylat & Ubiquitylat Unit, Dow St, Dundee DD1 5EH, Scotland
[2] EMBL, European Mol Biol Lab, Hamburg Unit, DESY, Notkestr 85, D-22607 Hamburg, Germany
基金
欧盟地平线“2020”; 英国医学研究理事会; 欧洲研究理事会;
关键词
SMALL-ANGLE SCATTERING; X-RAY-SCATTERING; UBIQUITIN RECOGNITION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; MOLECULAR-BASIS; CYLD USP; POLYUBIQUITIN; DIUBIQUITIN; ENZYME;
D O I
10.1016/j.molcel.2021.08.024
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Of the eight distinct polyubiquitin (polyUb) linkages that can be assembled, the roles of K48-linked polyUb (K48-polyUb) are the most established, with K48-polyUb modified proteins being targeted for degradation. MINDY1 and MINDY2 are members of the MINDY family of deubiquitinases (DUBs) that have exquisite specificity for cleaving K48-polyUb, yet we have a poor understanding of their catalytic mechanism. Here, we analyze the crystal structures of MINDY1 and MINDY2 alone and in complex with monoUb, di-, and pentaK48-polyUb, identifying 5 distinct Ub binding sites in the catalytic domain that explain how these DUBs sense both Ub chain length and linkage type to cleave K48-polyUb chains. The activity of MINDY1/2 is inhibited by the Cys-loop, and we find that substrate interaction relieves autoinhibition to activate these DUBs. We also find that MINDY1/2 use a non-canonical catalytic triad composed of Cys-His-Thr. Our findings highlight multiple layers of regulation modulating DUB activity in MINDY1 and MINDY2.
引用
收藏
页码:4176 / +
页数:22
相关论文
共 50 条
  • [1] MINDY1 promotes bladder cancer progression by stabilizing YAP
    Yongwen Luo
    Jun Zhou
    Jianing Tang
    Fengfang Zhou
    Zhiwen He
    Tongzu Liu
    Tao Liu
    [J]. Cancer Cell International, 21
  • [2] MINDY1 promotes bladder cancer progression by stabilizing YAP
    Luo, Yongwen
    Zhou, Jun
    Tang, Jianing
    Zhou, Fengfang
    He, Zhiwen
    Liu, Tongzu
    Liu, Tao
    [J]. CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [3] Study on the mechanism of liver cancer immune escape mediated by MINDY1 through regulation of PD-L1 ubiquitination level
    Song, Xingchao
    Li, Wenjin
    Tian, Chunyan
    Ma, Xiao
    Yang, Weibin
    Zhou, Jiahua
    [J]. BIOMOLECULES AND BIOMEDICINE, 2024,
  • [4] MINDY1 promotes breast cancer cell proliferation by stabilizing estrogen receptor α
    Jianing Tang
    Yongwen Luo
    Guo Long
    Ledu Zhou
    [J]. Cell Death & Disease, 12
  • [5] MINDY1 promotes breast cancer cell proliferation by stabilizing estrogen receptor α
    Tang, Jianing
    Luo, Yongwen
    Long, Guo
    Zhou, Ledu
    [J]. CELL DEATH & DISEASE, 2021, 12 (10)
  • [6] Correction to: MINDY1 promotes breast cancer cell proliferation by stabilizing estrogen receptor α
    Jianing Tang
    Yongwen Luo
    Guo Long
    Ledu Zhou
    [J]. Cell Death & Disease, 13
  • [7] MINDY1 Is a Downstream Target of the Polyamines and Promotes Embryonic Stem Cell Self-Renewal
    James, Christina
    Zhao, Tian Yun
    Rahim, Anisa
    Saxena, Parul
    Muthalif, Nazreen Abdul
    Uemura, Takeshi
    Tsuneyoshi, Norihiro
    Ong, Sheena
    Igarashi, Kazuei
    Lim, Chin Yan
    Dunn, Norris Ray
    Vardy, Leah A.
    [J]. STEM CELLS, 2018, 36 (08) : 1170 - 1178
  • [8] MINDY1 promotes breast cancer cell proliferation by stabilizing estrogen receptor α (vol 12, 937, 2021)
    Tang, Jianing
    Luo, Yongwen
    Long, Guo
    Zhou, Ledu
    [J]. CELL DEATH & DISEASE, 2022, 13 (01)
  • [9] 去泛素化酶MINDY1是肝癌细胞干性维持因子和肝癌不良预后的独立危险因素
    夏搏林
    刘科伟
    黄红霞
    沈美美
    王斌
    高建
    [J]. 中华肝脏病杂志, 2023, 31 (05)
  • [10] The deubiquitinating enzyme MINDY2 promotes pancreatic cancer proliferation and metastasis by stabilizing ACTN4 expression and activating the PI3K/AKT/mTOR signaling pathway
    Liu, Peng
    Liu, Songbai
    Zhu, Changhao
    Li, Yongning
    Li, Ying
    Fei, Xiaobin
    Hou, Junyi
    Wang, Xing
    Pan, Yaozhen
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13